Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aptevo Therapeutics (APVO) Other Non-Current Liabilities (2016 - 2024)

Aptevo Therapeutics' Other Non-Current Liabilities history spans 6 years, with the latest figure at $14000.0 for Q3 2024.

  • For Q3 2024, Other Non-Current Liabilities changed N/A year-over-year to $14000.0; the TTM value through Sep 2024 reached $14000.0, changed N/A, while the annual FY2018 figure was $200000.0, 72.75% down from the prior year.
  • Other Non-Current Liabilities for Q3 2024 was $14000.0 at Aptevo Therapeutics, roughly flat from $14000.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $14000.0 in Q1 2024 and bottomed at $14000.0 in Q1 2024.